HealthStream CTO granted 2,911 restricted share units

Cunningham Jeff reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Cunningham Jeff reported acquisition or exercise transactions in this Form 4 filing.

HealthStream Inc. Chief Technology Officer Jeff Cunningham received a grant of 2,911 restricted share units on March 18, 2026. Each unit represents one share of common stock, vesting over four years: 15% in 2027, 20% in 2028, 30% in 2029, and 35% in 2030. Following this grant, he directly holds 33,276 shares of common stock.

Insider Trade Summary

Grant/Award: 2,911 shares

Grant/Award 2 txns

Insider Cunningham Jeff

Role Chief Technology Officer

Type	Security	Shares	Price	Value
Grant/Award	Restricted Share Units	2,911	$0.00	$0.00
holding	Common Stock Holding	--	--	--

Holdings After Transaction: Restricted Share Units — 2,911 contracts (Direct); Common Stock Holding — 33,276 shares (Direct)

Footnotes (3)

1. F1. Each restricted share unit (RSU) represents the contingent right to receive one share of common stock upon vesting of the unit.
2. F2. The RSUs are subject to a four year vesting schedule, contingent upon continued service at the time of vesting. 15% vest on March 18, 2027, 20% vest on March 18, 2028, 30% vest on March 18, 2029, and the remaining 35% vest on March 18, 2030.
3. F3. Not applicable.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did HealthStream (HSTM) report for Jeff Cunningham?

HealthStream reported that Chief Technology Officer Jeff Cunningham received a grant of 2,911 restricted share units on March 18, 2026. These units represent future common shares subject to a multi‑year vesting schedule tied to continued service at the company.

How many restricted share units were granted to HealthStream CTO Jeff Cunningham?

Jeff Cunningham was granted 2,911 restricted share units. Each unit represents the right to receive one share of HealthStream common stock upon vesting, providing equity-based compensation that aligns his interests with shareholders over a four-year vesting period.

What is the vesting schedule for Jeff Cunningham’s 2,911 HealthStream RSUs?

The 2,911 RSUs vest over four years, contingent on continued service. 15% vest on March 18, 2027, 20% on March 18, 2028, 30% on March 18, 2029, and the remaining 35% on March 18, 2030, gradually delivering common shares.

What does each restricted share unit granted to Jeff Cunningham represent?

Each restricted share unit represents the contingent right to receive one share of HealthStream common stock upon vesting. The award does not deliver shares immediately; instead, shares are issued as vesting milestones are met over the four-year schedule.

How many HealthStream common shares does Jeff Cunningham hold after this Form 4?

After this reported grant, Jeff Cunningham directly holds 33,276 shares of HealthStream common stock. This figure reflects his direct ownership position as of the transaction date disclosed, separate from the 2,911 restricted share units that vest over time.

Is Jeff Cunningham’s RSU grant a purchase or a compensation award at HealthStream?

The 2,911 restricted share units are a compensation award, not an open-market purchase. The Form 4 uses transaction code A, indicating a grant or award acquisition, providing equity incentives contingent on continued employment and the defined vesting schedule.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/24/2026 - 04:37 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cunningham Jeff

(Last) (First) (Middle)

500 11TH AVENUE NORTH

SUITE 850

(Street)

NASHVILLE TENNESSEE 37203

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
HEALTHSTREAM INC [ HSTM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technology Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock Holding								33,276	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Share Units	(1)	03/18/2026		A		2,911		(2)	(3)	Common Stock	2,911	$0	2,911	D

Explanation of Responses:

1. Each restricted share unit (RSU) represents the contingent right to receive one share of common stock upon vesting of the unit.

2. The RSUs are subject to a four year vesting schedule, contingent upon continued service at the time of vesting. 15% vest on March 18, 2027, 20% vest on March 18, 2028, 30% vest on March 18, 2029, and the remaining 35% vest on March 18, 2030.

3. Not applicable.

	/s/ Jeff Cunningham	03/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)